Semper Paratus Acquisition
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
You can watch LGST and buy or sell other stocks, ETFs, and their options commission-free!About LGST
Tevogen Bio Holdings, Inc. is a clinical-stage specialty immunotherapy company, which engages in the provision of off-the-shelf therapies for the treatment of infectious diseases, cancers, and neurological disorders. It focuses on its product, ExacTcell, a technology that treats acute viral infections, long-term consequences of viral infections, and viral and non-viral induced cancers.
CEORyan Saadi, MD
CEORyan Saadi, MD
Employees18
Employees18
HeadquartersWarren, New Jersey
HeadquartersWarren, New Jersey
Founded
Founded
Employees18
Employees18
LGST Key Statistics
Market cap78.76M
Market cap78.76M
Price-Earnings ratio-2.27
Price-Earnings ratio-2.27
Dividend yield—
Dividend yield—
Average volume2.34M
Average volume2.34M
High today—
High today—
Low today—
Low today—
Open price—
Open price—
Volume0.00
Volume0.00
52 Week high$1.92
52 Week high$1.92
52 Week low$0.379
52 Week low$0.379
Stock Snapshot
As of today, Semper Paratus Acquisition(LGST) shares are valued at $0.40. The company's market cap stands at 78.76M, with a P/E ratio of -2.27.
Semper Paratus Acquisition(LGST) stock opened on 2025-12-15 at —. The price climbed to — and dipped to —.
Semper Paratus Acquisition(LGST) shares are trading with a volume of 0, against a daily average of 2.34M.
In the last year, Semper Paratus Acquisition(LGST) shares hit a 52-week high of $1.92 and a 52-week low of $0.38.
In the last year, Semper Paratus Acquisition(LGST) shares hit a 52-week high of $1.92 and a 52-week low of $0.38.
People also own
Based on the portfolios of people who own LGST. This list is generated using Robinhood data, and it’s not a recommendation.